Future Virology

Papers
(The TQCC of Future Virology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The Role of Artificial Intelligence in Tackling COVID-1978
A Brief Review on Dna Vaccines in the Era of COVID-1968
The Role of miRNAs in COVID-19 Disease60
Relationship Between IL-6 and COVID-19: to Be Considered During Treatment52
Exploring the Binding Efficacy of Ivermectin Against the Key Proteins of SARS-CoV-2 Pathogenesis: an in silico Approach49
Toll-like Receptor 4 in COVID-19: Friend Or foe?33
Natural Selection On Synonymous Mutations in SARS-CoV-2 and the Impact On Estimating Divergence Time27
Xerostomia (dry mouth) in Patients With COVID-19: A Case Series25
Potential anti-COVID-19 Activity of Egyptian Propolis Using Computational Modeling21
Fast Evolution of SARS-CoV-2 Driven by Deamination Systems in Hosts21
Myocarditis and COVID-19 Mrna Vaccines: A Mechanistic Hypothesis Involving dsRNA20
Predictive Values of Biochemical Markers As Early Indicators for Severe COVID-19 Cases in Admission19
Andrographolide Induces anti-SARS-CoV-2 Response Through host-directed Mechanism: anin silicoStudy18
Efficacy of Chloroquine and Hydroxychloroquine for the Treatment of Hospitalized COVID-19 Patients: A Meta-Analysis18
A Systematic Review and Meta-Analysis of the Sensitivity of Antibody Tests for the Laboratory Confirmation of COVID-1917
Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy17
Pandemic Response Management Framework Based On Efficiency of COVID-19 Control and Treatment16
The COVID-19 Pandemic: an Increased Risk of Rheumatoid Arthritis14
Cholesterol-lowering Drugs for High-Risk Hypercholesterolemia Patients with COVID-19 While on Paxlovid™ Therapy14
Efficacy of Lopinavir–Ritonavir Combination Therapy for the Treatment of Hospitalized COVID-19 Patients: A Meta-Analysis13
DPP-4 Inhibitors as a Savior for COVID-19 Patients with Diabetes12
Asymptomatic Carriers of Coronavirus Disease 2019 Among Healthcare Workers in Isfahan, Iran12
Evidence-Based Policies in Public Health to Address COVID-19 Vaccine Hesitancy12
Druggability of Cavity Pockets Within SARS-CoV-2 Spike Glycoprotein and pharmacophore-based Drug Discovery11
High-value Laboratory Testing for Hospitalized COVID-19 Patients: A Review11
In-hospital Clinical Complications of COVID-19: A Brief Overview11
An Overview of Sex Hormones in Relation to SARS-CoV-2 Infection11
Comparative Sequence Analysis of SARS-CoV-2 Suggests Its High Transmissibility and Pathogenicity10
Molecular and Antigen tests, and Sample Types for Diagnosis of COVID-19: A Review10
V483A: an Emerging Mutation Hotspot of SARS-CoV-210
Mechanisms of Infection By SARS-CoV-2, Inflammation and Potential Links With the Microbiome10
Identifying Asymptomatic Cases During the Mass COVID-19 Vaccination Campaign: Insights and Implications for Policy Makers10
What is the Intermediate Host Species of SARS-CoV-2?9
An Analysis of Inhibition of the Severe Acute Respiratory Syndrome Coronavirus 2 RNA-dependent Rna Polymerase By Zinc Ion: an in silico Approach9
Association Between Blood Groups and COVID-19 Outcome in Iranian Patients8
Targeting SARS-CoV-2 Nonstructural Protein 15 Endoribonuclease: an in silico Perspective8
Detection of SARS-CoV-2 in the Sewerage System in Tunisia: A Promising Tool to Confront COVID-19 Pandemic8
Can Natural Detergent Properties of Bile Acids Be Used Beneficially in Tackling Coronavirus disease-19?8
Association of Anemia and COVID-19 in Hospitalized Patients8
A New Perspective of the Chemistry and Kinetics of Inactivation of COVID -19 Coronavirus Aerosols8
Phylogenetic and Whole Genome Analysis of First Seven SARS-CoV-2 Isolates in Bangladesh8
A Comprehensive Account of SARS-CoV-2 Genome structure, Incurred mutations, Lineages and COVID-19 Vaccination Program8
Reinfection and Reactivation of SARS-CoV-27
Airborne Transmission of COVID-197
SARS-CoV-2 Likely Targets Cellular Pdz Proteins: A Common Tactic of Pathogenic Viruses7
Brain tissue-resident Immune Memory Cells are Required for long-term Protection Against CNS Infection With Rabies Virus7
Structural Analysis of Spike Proteins from SARS-CoV-2 Variants of Concern Highlighting Their Functional Alterations7
Efficacy and Safety of Corticosteroid Regimens for the Treatment of Hospitalized COVID-19 Patients: A meta-analysis7
Erythema multiform-like Lesions in a Patient Infected With SARS-CoV-2: A Case Report7
Potential Drugs Against COVID-19 Revealed By Gene Expression profile, Molecular Docking and Molecular Dynamic Simulation7
Research Progress in Vertical Transmission of SARS-CoV-2 Among Infants Born to Mothers with COVID-197
The Impact of Mutation Sets in Receptor-Binding Domain of SARS-CoV-2 Variants on Stability of the RBD–ACE2 Complex7
Phase II Study of Bemnifosbuvir in High-Risk Participants in a Hospital Setting with Moderate COVID-196
‘The end’ – Or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 Subvariants6
Neutralization Heterogeneity of Circulating SARS-CoV-2 Variants to Sera Elicited by a Vaccinee or Convalescent6
SARS-CoV-2 Direct real-time Polymerase Chain Reaction Testing in Laboratories With Shortage Challenges6
Investigation of the Relationship Between Inherited Thrombophilia and Novel Coronavirus Pneumonia6
Can Anti-Parasitic Drugs Help Control COVID-19?6
Massive Third-Wave COVID-19 Outbreak in Bangladesh: A Co-Epidemic of Dengue Might Worsen the Situation6
Nothing in SARS-CoV-2 Makes Sense Except in the Light of Rna modification?6
In silico Study of Potential anti-SARS Cell Entry Phytoligands From Phlomis aurea : A Promising Avenue for Prophylaxis6
Synthetic Antiviral Peptides: A New Way to Develop Targeted Antiviral Drugs5
Phylogenomics and Phylodynamics of SARS-CoV-2 Genomes Retrieved From India5
RT-LAMP is a Potential Future Molecular Diagnostic Tool for Influenza A Virus5
Scouting the receptor-binding Domain of SARS Coronavirus 2: A Comprehensive Immunoinformatics Inquisition5
Computational Guided Approach for Drug Repurposing Against SARS-CoV-25
Rare Cutaneous Manifestation of COVID-19 Infection and Pfizer-BioNTech COVID-19 Vaccine With a Unique Pattern Similarity5
Inpatient and Outpatient Costs Associated With Respiratory Syncytial Virus in Japanese Infants and Older Adults5
Detection and Predictors of anti-SARS-CoV-2 Antibody Levels in COVID-19 Patients at 8 Months After Symptom Onset5
Similarity Between Cutaneous Reactions Due to SARS-CoV-2 and Its Vaccinations5
The Initial Infectious Dose of SARS-CoV-2 and the Severity of the Disease: Possible Impact On the Incubation Period5
IgA Nephropathy and Spinal Epidural Abscess After COVID-19 Infection: A Case Report4
A Twisting Tale of Misinformation: Should Ivermectin be Approved as a Treatment for COVID-19 Disease?4
SARS-CoV-2 Nomenclature: viruses, Variants and Vaccines Need a Standardized Naming System4
The Novel Antiviral Properties of Brassicasterol Against Human Adenovirus4
In Silico Discovery of Non-Psychoactive Scaffolds in Cannabis Halting SARS-CoV-2 Host Entry and Replication Machinery4
Reappraisal of Trifluperidol Against Nsp3 As a Potential Therapeutic for Novel COVID-19: A Molecular Docking and Dynamics Study4
Vertical Transmission and Maternal Passive Immunity post-SARS-CoV-24
The Need for More Robust Research On the Effectiveness of Masks in Preventing COVID-19 Transmission4
Seroprevalence of the Hepatitis E Virus Antibodies Among Blood Donors in the Qassim region, Saudi Arabia4
Real-world Effectiveness of sofosbuvir/velpatasvir for the Treatment of Hepatitis C Virus in Prison Settings4
Association Between Human Herpesvirus-6 and Primary Brain Tumors: A Systematic Review and Meta-Analysis4
Global Epidemiology of HPV-Associated Recurrent Respiratory Papillomatosis and Effect of Vaccination4
The Third Booster Vaccination Dose Against COVID-19: Indications for Circulating SARS-CoV-2 Variants4
Anterior Ischemic Optic Neuropathy as a Rare Manifestation of COVID-19: A Case Report4
Oral Bemnifosbuvir (AT-527) Vs Placebo in Patients With mild-to-moderate COVID-19 in an Outpatient Setting (MORNINGSKY)4
Computed Tomography Evaluation of Pancreatic Steatosis: Correlation with COVID-19 Prognosis4
The Mu Strain: The Last but not Least Circulating ‘Variant of Interest’ Potentially Affecting the COVID-19 Pandemic4
0.037397861480713